Indonesia’s Vaccine Candidate To Combat Future Pandemics Is Now Under Clinical Trial

Indonesia – Pandemic has been with the world for two years already and nations try their best to formulate a new drug or vaccine to combat the transmissible virus. In view of this, The Merah Putih vaccine candidate, which is being developed by Indonesian scientists, is part of an initial effort launched to handle coronavirus pandemics in future.

The strategy implemented by BPOM for supporting the indigenous development of domestic vaccines involved seeking assistance from many parties, including PT Biotis Pharmaceutical Indonesia, which will work with Unair in testing its vaccine on human subjects.

For this reason, The protocol for the clinical trial of the Merah Putih vaccine must run according to the provisions, while ensuring the authenticity and validity of data so that the vaccine can be registered and cleared by BPOM for use. With the Merah Putih vaccine candidate, Indonesia is expected to be better equipped to cope with future pandemics more quickly.

Due to the urgent need for ensuring public health, vaccine development has been made a part of the government’s priorities, remarked Brodjonegoro, who also heads the National Research and Innovation Agency (BRIN).

Related Posts

In addition to this, Lukito said that BPOM has also been tasked with supporting the production facilities of the pharmaceutical industry. The goal is to have production facilities that meet the Good Laboratory Practices (GLP) standard or good drug production methods which was utterly explained. Along with this, It’s important to ensure that the production guarantees the quality, safety, and efficacy aspects (recorded) during research and clinical trials.

The COVID-19 pandemic has pushed BPOM to use various strategies to accelerate innovation and regulate clinical trials in the country, Lukito has shared. Consequently, There should have taken several years has been shortened while still prioritizing the aspects of quality, safety, and efficacy of pharmaceutical products.

Morever, BPOM has also intensified communication with the World Health Organization (WHO) and foreign drug regulators so that domestically produced vaccines can fulfill international standards in terms of quality and efficacy.

Noto

Jakarta-based Newswriter for The Asian Affairs. A budding newswriter that always keep track of the latest trends and news that are happening in my country Indonesia.

Recent Posts

Shooting concludes: Stranger Things 5 to release on Netflix in 2025

Created by the Duffer Brothers, Stranger Things is one of the most popular sci-fi horror series globally. It is set…

December 21, 2024

China’s Hypersonic Expansion in Asia Raises Alarms for India

According to the US Department of Defense, China has now produced the most sophisticated supply of hypersonic weapons in the…

December 21, 2024

Melaka International Halal Festival 2024

The Melaka International Halal Festival 2024 aims to turn the city as the prime center of the Halal products and…

December 21, 2024

Chunichi Dragons Renews the Contract of Hiroto Takahashi with Annual Salary of 120 million yen

On Saturday, the stalwart of Chunichi Dragons Pitcher, Hiroto Takahashi attended the negotiation for his contract renewal for the next…

December 21, 2024

Biden-Harris administration cancels another $4.28 billion in US student loans

US President Joe Biden has cancelled another $4.28 billion in student loans for nearly 55,000 people across the country, the…

December 20, 2024

The Colorful SCTV 2024 Carnival: Programs, Date, Venue & Timing

Music, dance, celebration and mesmerizing stage performances before the fans who are at the peak of their enjoyment, is the…

December 20, 2024

This website uses cookies.

Read More